by Bob Yirka , Medical Xpress Credit: CC0 Public Domain A team of researchers at Innovative Molecules GmbH, working with several other institutions in Germany, has developed a small-molecule therapy for the treatment of latent herpes simplex virus infections. In their paper published in the journal Science Translational Medicine, the group describes tweaking a drug used for treating...
OREGON STATE UNIVERSITY IMAGE: HOPS. CREDIT: OREGON STATE UNIVERSITY CORVALLIS, Ore. – Research by Oregon State University suggests a pair of compounds originating from hops can help thwart a dangerous buildup of fat in the liver known as hepatic steatosis. The findings, published today in eLife, are important because the condition affects roughly one-fourth of people in the...
by Vanderbilt University Medical Center From left, Taylor Smith, MS, Jacek Hawiger, MD, Ph.D., Jozef Zienkiewicz, Ph.D., and Yan Liu, MD, and colleagues developed a peptide that may protect against life-threatening microbial inflammation with underlying metabolic syndrome. Credit: Hawiger lab A cell-penetrating peptide developed by researchers at Vanderbilt University Medical Center can prevent, in an animal model, the...
Endometriosis, a disease found in up to 10 per cent of women, has been enigmatic since it was first described. A new theory developed by researchers at Simon Fraser University suggests a previously overlooked hormone — testosterone — has a critical role in its development. The research could have direct impacts on diagnosis and treatment of the disease, signaling...
REGENSTRIEF INSTITUTE IMAGE: Researchers from Regenstrief Institute and Indiana University School of Medicine have developed and validated a short, clinically practical questionnaire to help patients report symptoms and assist healthcare providers in assessing the severity of symptoms, and in monitoring and adjusting treatment accordingly. CREDIT: REGENSTRIEF INSTITUTE INDIANAPOLIS — Researchers from Regenstrief Institute and Indiana...
by University of Oxford Credit: University of Oxford People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic drug, which targets and suppresses the inflammatory cytokine GM-CSF. In a multicentre, dose-ranging trial, led by...
Thought LeadersDr. Nirmal RobinsonDr. Vincenzo DesiderioDr. Antonio Barbieri News-Medical spoke to researchers Dr. Nirmal Robinson, Dr. Vincenzo Desiderio, and Dr. Antonio Barbieri about their latest research into beta-blockers, and how they could potentially be used to treat COVID-19. What provoked your research into the current COVID-19 pandemic? We have been working on adrenergic receptors for...
by Ali Howard, University of Glasgow An international team of scientists, led by the University of Glasgow, has announced findings that could pave the way to a new treatment for asthma and chronic obstructive pulmonary disease (COPD). The breakthrough findings, published today in Science Translational Medicine, identify a new class of drugs that reverse the...
By NORMAN E. SHARPLESSAUGUST 13, 2020 This year’s annual release of cancer statistics generated more buzz than usual. Perhaps the most publicized finding in the Cancer Facts & Figures 2020 report was the 2.2% decline in overall cancer deaths from 2016 to 2017, the last year for which we have final statistics. That was the...
Multiple sclerosis (MS) is a debilitating demyelinating disease. It happens when the insulating covers of nerve cells in the brain and spinal cord are damaged and signal transmission in the nervous system becomes disrupted. Scientists at the University of Edinburgh found a way how the body could protect itself from the damages of MS. This...
